Since localizing IV solutions in 1959, JW Life Science has been advancing toward becoming a global CDMO, leveraging its proven expertise as the No. 1 leader in Korea’s IV solutions market.

Through its in-house research institute (HP R&D Center), the company has independently developed high-functionality non-PVC materials and a 3-chamber parenteral nutrition solution (Winuf), securing differentiated technological capabilities. Furthermore, exports to Europe in partnership with Baxter, compliant with EU-GMP standards, have fully demonstrated its manufacturing and quality excellence.

Building on this technology and expertise, JW Life Science aims to expand its presence across global markets—including Europe and the United States (with US FDA cGMP compliance underway)—and to grow as a true “Global Healthcare Partner.”